… validated a novel three-lipid signature associated with poor prognosis in CRPC. Further
research … modulation of lipid levels associated with poor prognosis can improve patient outcome. …

… circulating lipid profiles are associated with ADT/ARPI resistance in … Our two different
experimental approaches of studying ADT/… Prognostic Markers (plasma lipid prognostic signature …

… , a poor prognostic three-lipid signature (3LS) in the plasma of … prognosis in both castration
(mCRPC) and non-castration … with similar lipid profiles tend to have different cytokine profiles, …

… survival (rPFS) in mCRPC [14,15,16,17]. We have derived and validated a poor prognostic
3-lipid signature (… relationship between the poor prognostic 3-lipid signature, somatic genetic …

… treatment for mCRPC can modify a poor prognostic circulating lipidomic profile represented
by a validated 3-lipid signature (… received with simvastatin were also not significantly different …

… prognostic 3-lipid signature… signature was associated with poor outcome at different disease
stages, and elevated circulating sphingolipids, especially ceramides (Cer), were associated …

… signatures is limited. This study aims to identify castration-resistant PCa (CRPC)-associated …
Another unique aspect of this study is that both CRPC and HSPC samples used for DEGs …

… to castrate resistant PCa, … associated with metabolic and lipid-specific changes in PCa
patients. The role and relative contribution of lipid and glucose metabolism in PCa is different from …

… might be related to the different exposure to treatment, which is … (CNV) in plasma DNA are
associated with worse outcome in … prognostic effect of the previously reported 3-lipid signature …

… and validated a novel three-lipid signature associated with 303 poor prognosis in CRPC.
Further … 304 of lipid levels associated with poor prognosis can improve patient outcome. 305 …